Loading clinical trials...
Loading clinical trials...
Two Week Sub-chronic Double-blinded Placebo Controlled Trial Designed to Determine if Sodium Pyruvate Nasal Spray Will Reduce the Symptoms, Duration and Replication of COVID-19 Infection
Conditions
Interventions
Sodium Pyruvate
Saline
Locations
2
United States
Family First Medical Research Center
Virginia Gardens, Florida, United States
Missouri State University
Springfield, Missouri, United States
Start Date
April 12, 2021
Primary Completion Date
August 12, 2022
Completion Date
August 12, 2022
Last Updated
November 2, 2022
NCT06631287
NCT05101213
NCT04565665
NCT06871293
NCT04978571
NCT06082518
Lead Sponsor
Cellular Sciences, inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions